echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > How far is China away from US insurance companies to include multiple gene testing products?

    How far is China away from US insurance companies to include multiple gene testing products?

    • Last Update: 2015-08-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: Instrument Information Network August 24, 2015 US commercial insurance company included multiple gene detection products in the insurance coverage August 13 On the website of genomeweb, there are two news reports about the famous US commercial insurance company Noridian Medicare announcing that it will put multiple gene detection products in the local scope (LCD, local coverage decision) It is included in its own insurance coverage and fully reimbursed, including the well-known Myriad Genetics company which develops medical and molecular diagnosis products with genetic medicine and nanostring company which provides cancer gene detection services The former uses a variety of proprietary proteomic technology to discover disease genes, with a price of about 4000 US dollars each time The latter's breast cancer diagnostic kit, prosigna, predicts the incidence of breast cancer based on pam50 gene, which is closely related to the onset of breast cancer In fact, Noridian medicine is not the only insurance company in the United States that covets the value-added services brought by gene testing For example, last year, priority health included two products (foundation one and foundation heme) of foundation medicine into the scope of medical insurance, making it the first insurance company in the United States to include gene diagnosis products into medical insurance Cologuard, the colon cancer detection method produced by the company, was included in the federal medical insurance; bio theranomics' breast cancer gene detection program was officially included in the medical insurance reimbursement coverage program in October last year In January this year, Palmetto GBA, an insurance company, also launched insurance promotion of gene testing in some areas In addition, Anthem Blue Cross Blue Shield, an American medical insurance company, recently felt that non-invasive prenatal testing (NIPT) based on ngs technology was not only necessary for high-risk pregnancy, but also intended to expand the insurance business to the scope of general screening The green collaboration department of the center for medical technology policy (CMTP) recently proposed an important medical insurance policy for cancer high throughput sequencing (NGS), which aims to include multiple stakeholders including the pharmaceutical industry, professional social groups, patients and health plans Precision medicine helps genetic gene detection get more and more attention With the development of precision medicine, more and more people pay attention to genetic detection, which is very popular Since the first human gene was sequenced in 2003 (the cost was US $3 billion at that time), a large number of detection technologies and services related to gene began to emerge due to the technology update and cost reduction Now, there are thousands of diseases using genetic testing According to the most detailed data of NCBI, 26000 laboratory tests have been registered covering 5400 conditions and 3700 genes According to the market report released by the United Health Group, genetic testing is the fastest growing branch of the laboratory testing market In 2013, a whole genome sequencing cost only $6995, and genetic testing for individual consumers, such as 23andMe and ancetry.com, only $99 The United States currently spends $5 billion on genetic testing, which is expected to reach $15 billion to $25 billion by 2021 Why genetic testing? What's the point? Why genetic testing? What's the point? The National Institute of human genetics (NHGRI) of the United States has provided 7 categories of detection and definitions that are now relatively common Diagnostic testing is used to accurately determine the disease that causes the individual's illness The results can help the individual to make timely choices on how to treat or manage health; Prediction and genetic detection before symptoms are used to find gene changes that may increase the probability of an individual's disease The results can be used to predict the risk of an individual suffering from a specific disease, which may be helpful for the adjustment of the individual's lifestyle and health care; Carrier detection is used to find individuals with disease-related susceptibility genes The carrier itself may not have any disease phenotype, but they have the ability to pass the susceptibility genes on to the next generation, and so on The next generation may have diseases or become a new carrier For example, the detection of diseases caused by the susceptibility genes inherited from both parents must have a family history of genetic diseases Prenatal examination is used to help identify whether the fetus has some serious diseases during pregnancy; neonatal screening is used to check whether the newborn born one or two days has known diseases that will affect health and future development; Pharmacogenomic testing is used to provide information about how specific drugs work in the human body The results can help individual health care personnel select the most effective drugs according to your genetic composition; Research genetic testing is used to learn more about the contribution of genes to health and disease The results may not directly benefit the participants, but they can help researchers better understand the human body, health and disease, so as to promote the progress of medicine and health science and benefit future generations In conclusion, the significance of genetic gene detection can be divided into the following five points 1 Early understanding of the risk of breast cancer: gene detection can assess the genetic risk of breast cancer by detecting the sites related to breast cancer Gene detection shows that those with high genetic risk of breast cancer can avoid the risk factors of inducing breast cancer as early as possible and delay or prevent the occurrence of breast cancer 2 Guide personalized life: unhealthy life style is also a risk factor for breast cancer For gene test results, it is necessary to avoid the related unhealthy life style Keep a peaceful mind, maintain the relative balance of endocrine, balance diet, avoid bad environment, etc 3 Diagnosis of auxiliary breast disease: genetic testing (risk level) can be used as an auxiliary diagnostic means of breast disease, and its results can provide doctors with one-dimensional judgment basis 4 Guide the rational use of drugs, especially the safe use of estrogen related drugs 5 Help predict the risk of future generations: about 15% - 20% of breast cancer patients have a family genetic history Chinese insurance companies have begun to cooperate with gene detection companies With the rapid development of big data technology and algorithms, gene detection has entered a booming era The comprehensive use of genetic testing results, family health history, individual diet, life, sports, environment and other information, through big data to further establish a more personalized health risk prediction model, will have a wide and far-reaching impact on the whole human society, whether it is individual health, business economy, or environmental change and other fields At present, some insurance companies in China have also begun to cooperate with gene testing, such as Zhongan insurance and BGI to launch breast cancer gene testing and special health examination for breast cancer; Da'an gene and Taiping Life Insurance carry out "gene testing and health management" Services: in addition, Ping An Life Insurance, China Life Insurance Group, China People's Insurance Group, Taiping Life Insurance, Fude life insurance and other insurance institutions have contacted with gene testing institutions, and some of them have reached cooperation Gene detection and the next cooperation field of insurance companies: diagnosis and prevention of rare diseases In addition to the detection of prostate cancer, breast cancer and other cancer risk genetic genes provided by Myriad Genetics, 80% of them The above rare diseases are related to gene defects Mr Huang rufang, director of the center for the development of rare diseases, said that as long as there is life inheritance, there is the possibility of rare diseases In mainland China, the more familiar rare diseases include thalassemia, osteogenesis, mucopolysaccharide storage, ichthyosis, etc By 2020, the pathogenic genes of most of thousands of rare diseases can be found, which means that the diagnosis and prevention of rare diseases will be more effective.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.